{"name":"Corbus Pharmaceuticals Inc.","slug":"corbus-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CRB-601 monoclonal antibody","genericName":"CRB-601 monoclonal antibody","slug":"crb-601-monoclonal-antibody","indication":"Other","status":"phase_1"},{"name":"CRB-701","genericName":"CRB-701","slug":"crb-701","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"CRB-601 monoclonal antibody","genericName":"CRB-601 monoclonal antibody","slug":"crb-601-monoclonal-antibody","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CRB-701","genericName":"CRB-701","slug":"crb-701","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxONkk4bkRQNG1XcGpQRUp1UTd1Z2pjSEZINHpuYTA4cmVZbHdMSG5ySTgwejUxOV9XTjZsY2N3QjB4NjAwQm5UeGo4WDg1YUZtUDJoRXFVZzRKa2RJNlZUTEJTaWpEMS03dFkxM1JLalhuZGZtOEZzeW9Md2xSWllaR1FMN1MxMlBQb3NCVzg4XzhkMENmbUFjUHd6d09IYy1CYVV4c1BPX09UcTZSV3p2dFgzaUxqVGRiSHhVcGV5bFlRVmdyeHU5Sw?oc=5","date":"2026-04-07","type":"regulatory","source":"Benzinga","summary":"Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge - Corbus Pharmaceutical - Benzinga","headline":"Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge - Corbus Pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNNURfcFhGWTRONllPZ1Z2REc3WWJTZ0RmSmhlVHZVbmdRNlQ3b1NUYTBDVTVrZENmc002Q3pjcUVnTjhrSWg0R3FBT2ExeVZDVjFtSTFPMWVQdnRkc1NVVkd2bHVNQjh0a2l5M29xSlZ3eXphRVBiY1pQbjk5cnZIMGZuRU5oVTFJMUk0bDVHTk1RUmRyOVFfemJ4cndKZXZCSS1DOG1XNUdTYkxsZUNxT2cyOUtwMm5nYXc?oc=5","date":"2026-03-18","type":"trial","source":"Stock Titan","summary":"Obesity drug from Corbus shows rapid weight loss in early trial - Stock Titan","headline":"Obesity drug from Corbus shows rapid weight loss in early trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQY0FhNkFqMFpncFlLWTIxeC1oN29xX3hSRWFPVmRQR0Z1U29TMHZNaHQ2V0JrSHhyOWZIVGtXNm9QdDAxU09tQzEtYTJyQjc3V1RsSGpMRjJFNVFzNlFlVlVTNWNMSHJwNHpKVUpua1o3RDZYS1JMdlpZa01KT2tSODhtYnM?oc=5","date":"2026-03-09","type":"earnings","source":"Traders Union","summary":"Q4 and annual financial update released, Corbus Pharmaceuticals Holdings, Inc. outlines - Traders Union","headline":"Q4 and annual financial update released, Corbus Pharmaceuticals Holdings, Inc. outlines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPQ2VEa3M3N0ZrVmk3MWhkR0FDRDZHVU9fcE5LSGNCYkdyd3g3MHNVU3Y3amR6Nll1RnMyaTVpQlROTWg1ZDJJVjlpYlEybWxHYUhwcWY1ak9udWYwTy1mNmg3Z0lFT0FZUEp0SUhrWUJveE9tSk1mdmgzVWNKc1JXQkZEaTVWdkVRUkRXdEdOS2pqWW56OUZ5Wjh3Sl92OFg3akNGRk5JQWVWRFZhTnJpTnY1d1B1LVhacVRR?oc=5","date":"2026-03-09","type":"pipeline","source":"Stock Titan","summary":"Obesity drug shows 2.9% weight loss in 14 days at Corbus Pharma - Stock Titan","headline":"Obesity drug shows 2.9% weight loss in 14 days at Corbus Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOVkRrd1J3Ulk2bGJCdGNUUkVLM2FyWlBJOERRTWVCdktTZkNrbkxKQ3FGSWY0Ym5IY0hPdFdxZkhCcGp1MG1ONk1kR3lHV0RNZmpGRlc2Z1NZdTFJbUxVZU92T0R4bGhxeGdWanlsQ1ZOc0x2anZrZTJaZ0pzNS1yTHROSmpQRjBNSDhKRWVEZmdteDJqcUhmSWR2eUd2ZExNMzB5LUoySWRXVTlxc19ZbFdUM0NaaEtodGlrYnhpT0t3SGEyTnlldElFb1BFNUJjVS1ubEpnMGp5dWZqWDh1N1J4NE9hdFhWRnZEWkVR?oc=5","date":"2026-01-05","type":"pipeline","source":"GlobeNewswire","summary":"Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire","headline":"Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQdzRncktDNzRxX1JBNnQ4SDdQNDg4MFp6dWllRWozSHBDcnBDeUJ1c0R3TDZFd2dUYm1EVEhEb3FaMlVpT0Y2TmNxUWhxckR4QUdQdkxYTGJ2SjBZRzNCa092WHNLMDgxSVc4NjAtMkJSY2I2UXBlLVV5QVRtZW8xTXhBTTRac3FVYlFJS3lmbm4yLW56bUVFRDBhVmxOVWRLRlZxdWNkbVVGMTJiaHNJSkNIX3lfZw?oc=5","date":"2025-12-11","type":"trial","source":"Schaeffer's Investment Research","summary":"2 Pharma Stocks Pop on Strong Obesity Drug Trial Results - Schaeffer's Investment Research","headline":"2 Pharma Stocks Pop on Strong Obesity Drug Trial Results - Schaeffer's Investment Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOQjRCQTl4a0Nfc3ZvQ1NERUd1eUY3WGxOd1Qxb3Z0Z3VaR2tWc21PbWlPS1dvUWhKVzJNMDMtSl8wVDNteFJreXpldnVYZy0tRi1BYjlaeGl4Qkx0TXhGRi1WU0NmdTJ4czZYRldEUTIzdjFaNlREQUZKdGZMenhRZy1oNERQbUZNQlBEVnRfbGx0Qng4eVY4Zk5QLWtnUllaVFo3cndhS3NJMjRLeWNTUDgxYjFCTmNsaGkzQXBB?oc=5","date":"2025-12-11","type":"trial","source":"Stock Titan","summary":"Corbus Pharma (NASDAQ: CRBP) reports safe Phase 1a CRB-913 data, launches 12-week obesity study - Stock Titan","headline":"Corbus Pharma (NASDAQ: CRBP) reports safe Phase 1a CRB-913 data, launches 12-week obesity study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMDl0VzEzX3plUXQ4Ql9FZXg0RldmQlpRWFNyQ2p3TnA1Vi1KaGdUYVZPQmM4YzFucWV2NHBPcTJGQ0loUkdrakhfWUNaOXUyVURVVk1vZVdJVy1QLW5NaFRVSWtSVWFPVk54dDlOUUVNUjQyT3VSTmJEYU50dXN2cmZJTEJPckNjT09wbUNXZU9LRTVlMjFtYjlKNVpnUGZjd3lrZnhiTGJ0Ym55bl90eFI0eVVyYVZEemlZ?oc=5","date":"2025-12-10","type":"trial","source":"Quiver Quantitative","summary":"Corbus Pharmaceuticals to Announce Phase 1a Results for CRB-913 on December 11, 2025 | CRBP Stock News - Quiver Quantitative","headline":"Corbus Pharmaceuticals to Announce Phase 1a Results for CRB-913 on December 11, 2025 | CRBP Stock News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNX1NQejhrRnN2ajlOWjRPYjlabnRqdTBLdGs3eGpqbWVXNFZRVS04a1RGblFSRFpTRGhoNmRwZk9FcUNPaDc3SmYtMERqTngtUGtGZTdVbmNncnFUaklzYzVib2NDRjFDZWgtTkt0WUFmTjdVa1pIbHVQS1RLdGoxaXo5YkowZ0dDUWk3R1VPUmdZUnJTXy1McV9XVHZSUE0xM3hFTkVPTllZTktZQWRPREd0cjZTOXFNY0drYUlEWkhia0lKNE45QzJxVQ?oc=5","date":"2025-10-31","type":"pipeline","source":"GlobeNewswire","summary":"Corbus Pharmaceuticals Announces Pricing of Public Offering - GlobeNewswire","headline":"Corbus Pharmaceuticals Announces Pricing of Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWF9XVTJWZ3Zoc1Q2Z0V2b2NiTWp3S0RiU2V4N2M5MmVTekpiTW44bzhORGY4Z0h5QlpDS1ZJdmQxWDdzYTA5NklsZl9Kd1ZROHB6cGxaMmx5X3BReHdhd2tLRXZ3cmhhR251SmEydFE2NlgyTm5COE44WFpLVHR5SEU3X2NoN2FYMzZMNF90WjVybzliZ09feGdRNE5RUzhzWmtXNVBkYzlUWG1hMTdyYzZKc1pSWkE?oc=5","date":"2025-06-17","type":"trial","source":"seekingalpha.com","summary":"Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - seekingalpha.com","headline":"Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOeXNNOWV0S0VCYUFlcTVLbldwd2dEbkdkTi1feU5SSkMxMEx6UGlkbjRjenZxMkU0QlVYZkp6ODA2cEY2aENHTEtSeEVjbEFJaHU3RkFyamVpYk85RmZoeUtzTDJ5Y3h5cXpuaXRxek82SUJHb29xU0JGcGMyOVFrVTJB?oc=5","date":"2025-05-16","type":"pipeline","source":"Yahoo Finance","summary":"Is Small-Cap Corbus Pharma a Worthy Cannabis Investment? - Yahoo Finance","headline":"Is Small-Cap Corbus Pharma a Worthy Cannabis Investment?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOTXU3T3haVEFJbml3OVVBRi1semx3N01rYkdHVXl1R19peDJMY3d6YWQ3eFZybG5WTjUtLXVBVzBOVXRyRE1xTXFwdV9SQjdCR2tJS2t5QkdrUlhGa1JRQ1VPejdmUFAycTh3YlAyQWlVUUNwSjRvaGt5ZHN4cklBSURpbnlzOWRQZVZnMzVHazRHUFBjcVdfa3dNUVZuZnBQUG1oUGZ5ZjFqLVhrbVhtZkFyeUFfaEd5eVJoTjdDVldTMVNZUUxET0JiR2pEZ0h1bUk3M1V6LTJVU3hDX1c0YWJzVFNWNDZtc3dPX1VtcGc2QVpHa05wOUdlaUgxb055V2s2V0Y2a1pONC01bEpMcThJYWJfakg3?oc=5","date":"2023-02-13","type":"pipeline","source":"prnewswire.com","summary":"Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) - prnewswire.com","headline":"Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug ","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}